drugset / Press release

European Hematology Association Congress (EHA) 2019 – STRO-001 Poster

2019-06-15 · Sutro Biopharma, Inc. · original sutrobio.com ↗

Preliminary results of a Phase 1 dose escalation study of the first-in-class anti-CD74 antibody drug conjugate (ADC), STRO-001, in patients with advanced B-cell malignancies. Please Click the Link, EHA_2019 STRO-001 poster to enlarge.

The release as fetched from its publisher. sutrobio.com ↗